Taken together, this study demonstrates that USP22 promotes hepatocellular carcinoma growth and inhibits Sorafenib‐induced ferroptosis by deubiquitinating non‐histone substrate CDK11B and histone H2B, respectively. This evidence concerns the gene H2BC12L and hepatocellular carcinoma.